The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_016239.4(MYO15A):c.4198G>A (p.Val1400Met)

CA8423796

632271 (ClinVar)

Gene: MYO15A
Condition: nonsyndromic genetic deafness
Inheritance Mode: Autosomal recessive inheritance
UUID: 429026a9-22bf-43c4-8735-e5fb87686291

HGVS expressions

NM_016239.4:c.4198G>A
NM_016239.4(MYO15A):c.4198G>A (p.Val1400Met)
NC_000017.11:g.18131523G>A
CM000679.2:g.18131523G>A
NC_000017.10:g.18034837G>A
CM000679.1:g.18034837G>A
NC_000017.9:g.17975562G>A
NG_011634.1:g.27818G>A
NG_011634.2:g.27818G>A
ENST00000647165.2:c.4198G>A
ENST00000205890.9:c.4198G>A
ENST00000615845.4:c.4198G>A
NM_016239.3:c.4198G>A

Pathogenic

Met criteria codes 3
PP1_Strong PM3_Strong PP3
Not Met criteria codes 1
PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The allele frequency of the c.4198G>A (p.Val1400Met) variant in the MYO15A gene is 0.01980% (7/35356) of African/African-American chromosomes by gnomAD. This variant has been reported to segregate with hearing loss in at least 3 separate families (PP1_Strong; PMIDs: 27870113, 20642360; Partners LMM internal data SCV000966848.2). This variant has been detected in 10 probands with nonsyndromic hearing loss. For 2 of those probands, a pathogenic or suspected-pathogenic variant was observed in trans, in 1 a rare variant of unknown significance was observed in trans, and in 7 the variant was observed in the homozygous state (PM3_Strong; PMIDs: 27870113, 20642360; Partners LMM internal data SCV000966848.2). Additionally, the REVEL computational prediction analysis tool produced a score of 0.891, which is above the threshold necessary to apply PP3. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive nonsyndromic hearing loss based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PP1_Strong, PM3_Strong, PP3.
Met criteria codes
PP1_Strong
Identified in 3 separate families, each with one affected segregation, and at least one parent tested to rule out homozygous carrier status (PMIDs: 27870113, 20642360; LMM internal data).
PM3_Strong
Identified in 7 HL probands in homozygous state and 3 HL probands in compound heterozygous state across two publications and two internal LMM cases (PMIDs: 27870113, 20642360; LMM internal data). Total of 2.25 PM3 points, rounded to 2 PM3 points, leading to PM3_Strong applied.
PP3
REVEL = 0.891, which meets the threshold to apply PP3 (>0.7). Well conserved in UCSC.
Not Met criteria codes
PM2
Present in 7/35356 (0.01980%) of Latino/Admixed American alleles in gnomAD.
Approved on: 2021-07-27
Published on: 2022-05-13
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.